Atlas Trials

Acute Myeloid Leukemia With FLT3/ITD Mutation

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Acute Myeloid Leukemia With FLT3/ITD Mutation

RecordFirmDate
Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML (NCT05024552)H. Lee Moffitt Cancer Center and Research Institute2022-02-25
AML Patients Bearing FLT3 Mutations Based on Peripheral Blast Clearance (NCT04174612)Gruppo Italiano Malattie EMatologiche dell'Adulto2020-04-24
Venetoclax and Quizartinib in Treating Patients With FLT3-mutated Recurrent or Refractory Acute Myeloid Leukemia (NCT03735875)M.D. Anderson Cancer Center2019-01-25
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer (NCT03333486)Roswell Park Cancer Institute2017-12-07
Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation (NCT02634827)Mayo Clinic2015-12-30
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies (NCT01760655)Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2012-12-24
Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia (NCT01578109)National Cancer Institute (NCI)2012-01-13
Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia (NCT01253070)National Cancer Institute (NCI)2011-04-01
Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT01028716)Fred Hutchinson Cancer Center2010-05-19

Track Acute Myeloid Leukemia With FLT3/ITD Mutation automatically

Every clearance here is in the API, with alerts when new ones post.